Background: Hospital admissions for acute recreational drug toxicity are coded using the International Classification of Diseases (ICD-10) coding system. It is unclear how these admissions are coded, as often there are no specific ICD-10 codes for the drug(s) involved. This study was undertaken to determine how acute recreational drug toxicity admissions are routinely coded. Design: Questionnaire survey. Methods: Questionnaires were sent to clinical coding departments in all England and Wales acute National Health Service Trusts, comprising of 12 hypothetical discharge summaries (4 acute recreational drug toxicity for which there are no appropriate ICD-10 codes, 5 other toxicological presentations with appropriate ICD-10 codes available and 3 control medical admissions), and they were asked to code these discharge summaries.
Introduction
Acute recreational drug toxicity is a common cause of presentation to the Emergency Department (ED) and hospital admission in many countries, and patterns of use of recreational drugs are constantly changing. 1 Appropriate clinical care of acute recreational drug toxicity requires knowledge of the patterns of toxicity associated with these drugs; such evidence often comes primarily from retrospective reviews of case notes. [2] [3] [4] [5] [6] In addition, there is a public health need for epidemiological surveillance of morbidity due to acute recreational drug toxicity, in order to guide service provision and legislative decisions regarding the classification of both established and novel recreational drugs. All of these require accurate case identification based on coded admission diagnoses.
In the UK, all admissions to National Health Service (NHS) hospitals are coded using International Classification of Disease Version 10 (ICD-10) codes. 7 Each admission is given a 'primary code', denoting the principal reason for admission, and potentially a number of 'secondary codes' denoting co-existing medical conditions, other diagnoses made during the hospital stay or information in relation to the 'circumstances' of the other codes used for the admission. The codes are used to aid allocation of funds to hospitals depending on the case mix, and the compiled data from these codes, known as Hospital Episode Statistics (HES), is used for epidemiological studies and health service planning. It is therefore important that this coding system is accurate.
A study of the coding of patients presenting to a large hospital in London with acute recreational drug toxicity found that many patients were not appropriately coded; only 44% of all coded presentations were coded with a primary ICD-10 code that related to acute recreational drug toxicity. 8 This may be because of deficiencies in the ICD-10 coding system, which does not have specific codes for toxicity due to many common recreational drugs. 9 In order to be able to make recommendations for future revisions of ICD-10, and to assist current research using HES, it is necessary to know how presentations with recreational drug toxicity are routinely coded by hospital coding departments.
Methods
We sent a postal survey to the Clinical Coding Departments of 176 acute hospital trusts in England and Wales, asking which primary and secondary ICD-10 codes they would usually use to code a set of discharge summaries for 12 hypothetical patients (see Supplementary Data). We generated these discharge summaries in conjunction with the coding department at our large inner-city teaching hospital. While they were intended to be realistic, they were not based on any particular real patients. They included 4 examples of acute recreational drug toxicity for which there is no obvious ICD-10 code or no code for the specific drug which was taken: palpitations due to mephedrone (4-methylmethcathinone); gamma-butyrolactone (GBL) toxicity and withdrawal; seizure due to ecstasy (3,4-methylenedioxymethamphetamine, MDMA); and agitation due to benzylpiperazine. There were 5 other toxicological presentations: chest pain in a first-time user of cocaine; chest pain in regular user of cocaine; coma due to methadone and heroin overdose; a body stuffer with possible opiate toxicity from a swallowed packet; and alcohol intoxication. Three non-toxicological admissions were included as 'controls' as they had similar presentations to some of the recreational drug cases: an epileptic seizure; supraventricular tachycardia; and chest pain due to probable unstable angina.
The initial survey was sent in July 2010; nonresponders were sent a follow-up letter in September 2010. This report contains responses received by the end of December 2010.
Results
A total of 70 responses were received, with 64-69 responses for each hypothetical case. Table 1 shows that the non-toxicological and alcohol cases had similar primary codes assigned by all respondents. The opiate overdose had a primary code for methadone or heroin in 95.6% of the responses. The body stuffer case had a wide range of primary codes (13 different codes among 69 responses), of which the most common were 'Observation for suspected toxic effect from ingested subs' (23.2%) and 'Poisoning by Heroin' (20.3%). For the two cases of cocaine-related chest pain, only 37.5% of responses assigned cocaine toxicity as the primary diagnosis; one stated stimulant use and the others stated chest pain. The ecstasy case was coded as 'Poisoning by psychostimulants with abuse potential' by 82.1% of respondents.
We also considered the combination of primary and secondary codes selected for each toxicological case ( Table 2 , Supplementary Data). All respondents assigned a code for poisoning or drug toxicity among the primary and secondary codes for the cases of mephedrone, GBL, ecstacy and benzylpiperazine toxicity; in 98% of cases this was the primary code. However, there are no specific ICD-10 codes for these drugs and so it would not be possible to identify the drugs involved through the ICD-10 coding assigned. Appropriate codes for substance toxicity were assigned in all responses for the alcohol intoxication and methadone/heroin overdose cases, but for the case of chest pain after first time cocaine use, only 72.5% of respondents included an ICD-10 code for cocaine toxicity among the primary and secondary codes. In the body stuffer case, the clinical summary stated there was a suspicion of opioid toxicity but this was not definite, so only a small proportion of respondents (23.2%) assigned an opioid toxicity code, although a larger proportion (63.8%) assigned a non-specific toxicology code.
Discussion Summary of main findings
We found that Clinical Coding would assign a wide variety of ICD-10 codes to admissions for recreational drug toxicity, particularly for novel recreational drugs for which there is no specific ICD-10 code. In some cases, such as cocaine-related chest pain, the primary code assigned was more likely to relate to the chest pain symptom rather than recreational drug use which is the underlying cause. However, a less specific code for poisoning or drug toxicity was included among the primary and secondary codes in most cases; importantly this would not allow identification of the drug(s) involved from the ICD-10 code.
Strengths and limitations
This is the first study we are aware of that has sought to determine how acute recreational drug toxicity presentations are coded, in particular for those drugs for which there is no specific ICD-10 code. A strength of our study was that the questionnaire did not specifically state that the survey was about recreational drug presentations, as this may have biased the respondents to be more likely to select toxicological diagnoses as the primary diagnosis. Our hypothetical cases also included a number of general medical cases as controls, and the fact that these were allocated the same ICD-10 code by virtually all coders shows that hospitals are generally consistent in their coding of common conditions which have well-defined ICD-10 codes.
The main limitations of this study are the small sample size and potential for bias arising from the low response rate (39.8%), and the fact that it is based on hypothetical rather than actual recreational drug presentations. However, based on our own clinical experience, we feel that the cases we used are representative of those presenting to hospitals in the UK with recreational drug toxicity. Also, for practical reasons we provided only discharge summaries rather than complete clinical case notes. Although it is good coding practice to review the entire clinical record when assigning diagnostic codes to an admission episode, a Royal College of Physicians coding audit in 2009 found that many coding departments rely primarily on the discharge letter, particularly for short admissions, 10 and in this sense our survey represents common practice in many hospitals.
Clinical and research implications
The under-recording of cases of recreational drug toxicity will result in underestimation of the scale of the problem, with consequent under-allocation of resources for dealing with recreational drug use. Without accurate case identification it is also difficult to accumulate knowledge on the true epidemiology of acute recreational drug toxicity and importantly on the patterns of toxicity of novel and emerging recreational drugs, which is necessary both to aid and inform clinical management and to inform legislative bodies. An additional limitation of HES is that it only captures information on patients admitted to hospital; a significant proportion of patients presenting with acute recreational drug toxicity are not admitted to hospital. The system thus fails to capture the burden of work associated with acute recreational drug toxicity for Emergency Departments. Some Emergency Departments have begun to code emergency presentations using ICD-10 and report this to a pilot form of HES known as A&E HES, but this also has limitations, particularly as the A&E HES data uses even broader diagnostic codes than the main HES data. 8 
Potential solutions
We would recommend that future revisions of ICD-10 include specific codes for the more common recreational drugs; however, it would be difficult for any coding system to have a specific code for each novel recreational drug that comes onto the market. Nevertheless a number of drugs that are widely used 1, 11 and have been reported to cause toxicity for over 15 years such as MDMA and gammahydroxybutyrate (GHB) have not been included within ICD-10.
12,13
Through our specialist clinical toxicology service at our large inner-city teaching hospital, details of all toxicological presentations are prospectively entered on a database by a dedicated database scientist.
14 This is the best method for fully capturing the morbidity of recreational drug toxicity presenting to hospital, but it would be prohibitively expensive to roll out to all acute hospitals. Additionally, the currently available coding systems, including the ICD system, is not able to adapt in a meaningful timeframe that would allow inclusion of novel recreational drugs as they emerge onto the recreational drug scene. However, there is the potential for the development of a system of collection of a minimum data set in relation to acute recreational drug presentations to a number of sentinel hospitals/ Emergency Departments in the UK. This system would be more adaptable to the rapidly changing recreational drug scene, and would allow the inclusion of novel recreational drugs as their availability and/or use becomes apparent. This has been previously successfully undertaken on a smaller scale between our clinical toxicology service in the UK and a specialist centre in a hospital in Mallorca, Spain. 15 Alternatively, with the development and introduction of electronic health records in hospitals, there is the possibility for doctors to record the names of substances taken prospectively in a structured data area, so that summary data can be compiled more accurately on a regional or national level. This would also allow data to be captured on novel recreational drugs as they emerge onto the recreational drug scene. At this time, the infrastructure is not available to undertake this type of activity and there would be the need to address potential concerns of data confidentiality through data sharing.
Conclusions
Hospital admissions due to many recreational drugs, both established drugs such as ecstasy (MDMA) and novel drugs such as mephedrone for which there is no specific ICD-10 code, can be assigned a wide variety of primary codes by clinical coders. In some cases, the primary code assigned is more likely to relate to the symptom rather than recreational drug use which is the underlying cause. This means that many acute recreational drug toxicity cases cannot be identified through the primary or secondary ICD-10 code and therefore are not likely to be able to be identified through the HES. We recommend that future revisions of the ICD coding system should include more specific codes for recreational drug toxicity, particularly those established recreational drugs such as MDMA and GHB that have not already been included in this coding system. There is also the potential for the development of a network of appropriately funded sentinel centres in the UK, within hospitals or Emergency Departments within areas of a high prevalence of recreational drug use, to capture a minimum data set on presentations with acute recreational drug toxicity. This system of sentinel centres has the adaptability to incorporate novel recreational drugs as evidence of their availability and use emerges, so that the data collected remains as up to date as possible.
Supplementary Data
Supplementary Data are available at QJMED online.
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